ClinicalTrials.gg
CompletedNCT07050615Updated Jul 3, 2025

Comparison of the Frequency of Post-Operative Pain of Continuous Versus Interrupted Suturing Techniques in Episiotomy

An interventional study of Continuous suturing and Interrupted suturing in Post Operative Pain, sponsored by RESnTEC, Institute of Research. Completed at 1 site in Pakistan. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-07-03.

Sponsored by RESnTEC, Institute of Research · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Aug 2024, registered Jun 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 137 studies in Pain, Postoperative with a site in Pakistan — 41 open to participants now, 45 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.

Enrollment
51st of 135
86 · median 78
Started
2024
with 16 others
No phase
86 of 137
27 open now
Registered
73rd of 137
by date

Among the 137 studies in Pain, Postoperative with a site in Pakistan, this one is the 51st largest by enrollment of the 135 interventional ones that give a count, is one of 17 that started in 2024, is one of 86 with no phase, and was the 73rd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

41 of the 137 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 20 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 137 studies in Pain, Postoperative with a site in Pakistan, or all of them as a file.
02

Study summary

Post-operative pain is the most prevalent issue following an episiotomy, greatly affecting patients both physically and mentally, resulting in increased morbidity. This study seeks to compare the effectiveness of continuous and interrupted suturing techniques for episiotomy post-operative pain among the local population.

Read the detailed description

There is a lack of recent local data regarding the management of post-operative pain using different suturing techniques. The findings of this study would help in adopting a more effective technique, resulting in reducing the postoperative pain and lowering morbidity. Practical recommendations can be made to enhance routine practices and establish guidelines for these patients.

03

Conditions studied

  • Post Operative Pain

Browse trials for

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant females
  • Aged 20-40years
  • Undergoing an episiotomy to facilitate the delivery of the head in the labor room
  • First or second pregnancy
  • Gestational age of 37-41+6 weeks

Exclusion criteria

Exclusion Criteria:

  • Females, undergone an instrumental vaginal delivery
  • With a history of previous perineal surgery
  • With high-risk pregnancies (those having hypertension, anemia or bleeding tendency, diabetes mellitus, a suspected genital infection)
  • With impaired immunity
  • Taking
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Continuous group

    In this group patients under going episiotomy, went through continuous suturing

    Procedure: Continuous suturing

  • Experimental
    Interrupted group

    In this group patients under going episiotomy, went through interrupted suturing

    Procedure: Interrupted suturing

Interventions

  • ProcedureContinuous suturing

    In this group, episiotomy repair was done using the continuous suturing.

  • ProcedureInterrupted suturing

    In this group, episiotomy repair was done using the interrupted suturing.

06

What researchers measure

Primary outcomes

  1. Post operative pain

    Post-operative pain (yes/no) was noted using the visual analogue scale (VAS).

    Time frame: 48 hours

07

Study locations

1 site
  • Shahida Islam Medical Complex
    Lodhran, Punjab Province 59320, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Data can be shared on a reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Jan 2025, 5 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 5 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Jul 3, 2025
StartActual
Aug 1, 2024
Primary completionActual
Jan 31, 2025
CompletionActual
Jan 31, 2025
Last update
Jul 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07050615
Lead sponsor
RESnTEC, Institute of Research
Responsible party
Sponsor
First posted
Jul 3, 2025
Start date
Aug 1, 2024
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025
Last update
Jul 3, 2025

Study contacts

Arooj Akram
principal investigator · Shahida Islam Medical Complex, Lodhran
Joveria Sadaf
principal investigator · Shahida Islam Medical Complex, Lodhran

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion